Should You Use A GLP-1 To Reduce Body Fat?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Already a member? Sign In

Timeline

00:00

A 55-year-old man using testosterone, Masteron, metformin, and Bystolic asks about adding a GLP-1 medication to reduce body fat, and Dr. O’Connor discusses effectiveness, appetite suppression, nausea, vomiting, and the need for caution.

Video Summary

A 55-year-old man on testosterone asks whether a GLP-1 medication could help reduce body fat. Dr. O’Connor reviews his current use of testosterone, Masteron, metformin, Bystolic, curcumin, and CoQ10 before discussing medications such as semaglutide and Mounjaro.

Dr. O’Connor explains that GLP-1-based medications can be effective but may strongly suppress appetite and cause nausea or vomiting. Because the member is 55 and already using several medications, he recommends proceeding carefully rather than automatically adding another drug.

Metformin is discussed as a potentially simpler option depending on the member’s goals and metabolic health. Dr. O’Connor closes by emphasizing continued ABCDs™ monitoring while deciding whether additional weight-management medication is appropriate.

Drug Callouts

Semaglutide

Semaglutide is discussed as a GLP-1 medication that can help with body-fat reduction. Dr. O’Connor says these medications can work well but may strongly suppress appetite and cause gastrointestinal side effects such as nausea and vomiting.

Mounjaro

Mounjaro is mentioned alongside semaglutide as a medication used for weight and metabolic management. Dr. O’Connor emphasizes that these medications can be effective but may substantially reduce appetite and produce nausea or vomiting in some patients.

Metformin

The member is already using metformin, and Dr. O’Connor suggests that continuing with metformin may be worth considering before automatically adding a GLP-1 medication. The decision should be guided by the member’s metabolic health and broader ABCDs™ monitoring.

Key Takeaways

GLP-1-based medications can support body-fat reduction but may substantially suppress appetite and cause nausea or vomiting.
A 55-year-old already using several medications should approach the addition of another metabolic drug carefully.
Metformin may remain a reasonable option to consider before automatically adding a GLP-1 medication.
Weight-management decisions should remain connected to the member’s broader metabolic health and ABCDs™ monitoring.